Patents by Inventor Halime SIGINC

Halime SIGINC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biological markers in the diagnosis of endometriosis
    Patent number: 12699103
    Abstract: Combinations of the novel biological markers that can be used in the diagnosis of endometriosis are provided. The objective of the invention is to detect biological markers that are expressed differently in eMSCs isolated from endometrial biopsy samples in the diagnosis of endometriosis compared to healthy eMSCs. A tissue transglutaminase is configured as a biomarker for a diagnosis of an endometriosis in isolated endometrial mesenchymal stem cells derived from an endometrial biopsy and/or a menstrual blood from endometriosis patients.
    Type: Grant
    Filed: May 20, 2022
    Date of Patent: August 4, 2026
    Assignee: YEDITEPE UNIVERSITESI
    Inventors: Inci Kurt Celep, Dilek Telci Temeltas, Fikrettin Sahin, Melike Batukan, Halime Siginc
  • NOVEL BIOLOGICAL MARKERS IN THE DIAGNOSIS OF ENDOMETRIOSIS
    Publication number: 20240241134
    Abstract: Combinations of the novel biological markers that can be used in the diagnosis of endometriosis are provided. The objective of the invention is to detect biological markers that are expressed differently in eMSCs isolated from endometrial biopsy samples in the diagnosis of endometriosis compared to healthy eMSCs. A tissue transglutaminase is configured as a biomarker for a diagnosis of an endometriosis in isolated endometrial mesenchymal stem cells derived from an endometrial biopsy and/or a menstrual blood from endometriosis patients.
    Type: Application
    Filed: May 20, 2022
    Publication date: July 18, 2024
    Applicant: YEDITEPE UNIVERSITESI
    Inventors: Inci KURT CELEP, Dilek TELCI TEMELTAS, Fikrettin SAHIN, Melike BATUKAN, Halime SIGINC